Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 61

Results For "advance"

3170 News Found

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


New support group targets delayed diagnosis of Vasculitis in India
Healthcare | April 20, 2026

New support group targets delayed diagnosis of Vasculitis in India

Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide


Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts
Healthcare | April 20, 2026

Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts

Medical experts point to a growing body of research linking energy drinks to liver injury


MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
Healthcare | April 20, 2026

MicrobioTx launches IBS Risk Score to enable early detection of gut disorder

The launch coincides with IBS Awareness Month in April


Novartis CEO Vas Narasimhan joins Anthropic board
People | April 20, 2026

Novartis CEO Vas Narasimhan joins Anthropic board

Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery


NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
R&D | April 20, 2026

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


Precision BioSciences expands Hepatitis B gene editing trial into France and Romania
Biotech | April 20, 2026

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania